Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

Gender disparities in lipid-lowering therapy among veterans with diabetes.

Vimalananda VG, Miller DR, Palnati M, Christiansen CL, Fincke BG.

Womens Health Issues. 2011 Jul-Aug;21(4 Suppl):S176-81. doi: 10.1016/j.whi.2011.04.009.

PMID:
21724138
[PubMed - indexed for MEDLINE]
2.

A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization.

Valuck RJ, Williams SA, MacArthur M, Saseen JJ, Nair KV, McCollum M, Ensor JE.

Clin Ther. 2003 Nov;25(11):2936-57.

PMID:
14693317
[PubMed - indexed for MEDLINE]
3.

Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans.

Vimalananda VG, Miller DR, Hofer TP, Holleman RG, Klamerus ML, Kerr EA.

J Gen Intern Med. 2013 Jul;28 Suppl 2:S529-35. doi: 10.1007/s11606-013-2340-5.

PMID:
23807061
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System.

Gellad WF, Good CB, Lowe JC, Donohue JM.

Am J Manag Care. 2010 Oct;16(10):741-50.

PMID:
20964470
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Disparities in use of lipid-lowering medications among people with type 2 diabetes mellitus.

Safford M, Eaton L, Hawley G, Brimacombe M, Rajan M, Li H, Pogach L.

Arch Intern Med. 2003 Apr 28;163(8):922-8.

PMID:
12719201
[PubMed - indexed for MEDLINE]
6.

LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.

Nag SS, Daniel GW, Bullano MF, Kamal-Bahl S, Sajjan SG, Hu H, Alexander C.

J Manag Care Pharm. 2007 Oct;13(8):652-63.

PMID:
17970603
[PubMed - indexed for MEDLINE]
Free Article
7.

Decomposing gender differences in low-density lipoprotein cholesterol among veterans with or at risk for cardiovascular illness.

Sambamoorthi U, Mitra S, Findley PA, Pogach LM.

Womens Health Issues. 2012 Mar;22(2):e201-8. doi: 10.1016/j.whi.2011.08.012. Epub 2011 Dec 1.

PMID:
22133598
[PubMed - indexed for MEDLINE]
8.

Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT/EDIC.

Larkin ME, Backlund JY, Cleary P, Bayless M, Schaefer B, Canady J, Nathan DM; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

Diabet Med. 2010 Apr;27(4):451-8. doi: 10.1111/j.1464-5491.2010.02972.x.

PMID:
20536518
[PubMed - indexed for MEDLINE]
9.

Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.

Clin Ther. 2007 Aug;29(8):1671-81.

PMID:
17919548
[PubMed - indexed for MEDLINE]
10.

Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.

Zhang Q, Rajagopalan S, Mavros P, Engel SS, Davies MJ, Yin D, Radican L.

Curr Med Res Opin. 2010 Jul;26(7):1697-703. doi: 10.1185/03007995.2010.489029.

PMID:
20465367
[PubMed - indexed for MEDLINE]
11.

Racial disparities in diabetes care processes, outcomes, and treatment intensity.

Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA.

Med Care. 2003 Nov;41(11):1221-32.

PMID:
14583685
[PubMed - indexed for MEDLINE]
13.

Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease.

Majumdar SR, Gurwitz JH, Soumerai SB.

J Gen Intern Med. 1999 Dec;14(12):711-7.

PMID:
10632815
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.

Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ.

Arch Intern Med. 1996 Jun 10;156(11):1181-8.

PMID:
8639012
[PubMed - indexed for MEDLINE]
15.

The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medication.

Freiberg MS, Leaf DA, Goulet JL, Goetz MB, Oursler KK, Gibert CL, Rodriguez-Barradas MC, Butt AA, Justice AC.

J Gen Intern Med. 2009 Mar;24(3):334-40. doi: 10.1007/s11606-008-0891-7. Epub 2009 Jan 6.

PMID:
19127386
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization.

Nau DP, Mallya U.

Am J Manag Care. 2005 Feb;11(2):69-73.

PMID:
15726854
[PubMed - indexed for MEDLINE]
Free Article
17.

Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.

Udawat H, Goyal RK.

Indian Heart J. 2001 Mar-Apr;53(2):172-6.

PMID:
11428472
[PubMed - indexed for MEDLINE]
18.

Adherence to lipid-lowering agents among 11,042 patients in clinical practice.

Wong MC, Jiang JY, Griffiths SM.

Int J Clin Pract. 2011 Jul;65(7):741-8. doi: 10.1111/j.1742-1241.2011.02706.x.

PMID:
21676117
[PubMed - indexed for MEDLINE]
19.

Treatment and control of BP and lipids in patients with hypertension and additional risk factors.

Welch V, Tang SS.

Am J Cardiovasc Drugs. 2007;7(5):381-9.

PMID:
17953476
[PubMed - indexed for MEDLINE]
20.

Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study.

Massing MW, Foley KA, Carter-Edwards L, Sueta CA, Alexander CM, Simpson RJ Jr.

BMC Cardiovasc Disord. 2004 Aug 18;4:15.

PMID:
15317654
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk